Introducing the RevolveSD Series by CPC Biotech
CPC Biotech, a prominent player in the biopharmaceutical manufacturing sector, has recently rolled out the RevolveSD™ Series, an innovative one-inch, single-use sterile disconnect designed specifically for bioprocessing applications. This new product marks a significant advancement in the industry, streamlining the process of sterile disconnection of bioprocess tubing with remarkable efficiency.
The Need for Simplicity in Bioprocessing
In the complex world of biopharmaceutical production, the need for reliable and efficient components is paramount. Traditionally, processes like sterilization and disconnection have required multiple steps involving clamps or sealers, which can be cumbersome and time-consuming. CPC Biotech created the RevolveSD connectors with the aim of simplifying these procedures.
Spencer Juola, product manager at CPC Biotech, emphasizes this point: “Operators can disconnect tubing without special equipment, and the true one-time disconnect feature helps prevent any unintended reconnections. This significantly reduces the associated risks that could compromise the sterility of the process.”
The new connects are designed for speed; operators can complete sterile disconnections in mere seconds, ultimately minimizing setup time and allowing for a more agile workflow in bioprocessing environments.
Enhanced Design and Compatibility
The RevolveSD Series is crafted from durable polyphenylsulfone (PPSU), a lightweight material known for its compatibility with harsh chemicals often used in bioprocessing applications, including those for antibody drug conjugates. Notably, its metal-free construction reduces the risk of corrosion and enhances the longevity of the components during use.
Moreover, the design features dual-valve, non-spill technology that effectively minimizes residual fluid in the valve after disconnection. This thoughtful engineering supports smooth, bidirectional flow, ensuring minimal turbulence and restriction, which are critical factors for maintaining process integrity in large-scale applications.
Industry Feedback and Future Implications
Early adopters of the RevolveSD Series have provided positive feedback, noting it addresses a pressing need within the industry for high-flow, sterile, single-use disconnect options that are user-friendly. Juola stated that as manufacturers and bioprocessors navigate increasing demands for efficiency, products like the RevolveSD become invaluable in simplifying fluid disconnections and reducing complexities during tear-down.
CPC Biotech has long established a reputation for providing robust solutions tailored to the demanding needs of the bioprocessing sector, and the RevolveSD Series is an extension of that legacy. The introduction highlights the company’s commitment to advancing the capabilities of biopharmaceuticals, ensuring innovators can focus on producing high-quality medicines with confidence in process reliability.
For those interested in exploring the performance and versatility of the RevolveSD Series further, additional information can be found on the
CPC Biotech website.
A Leading Force in Bioprocessing
CPC Biotech remains at the forefront of bioprocessing fluid management and control, boasting a comprehensive range of critical components that are instrumental in the development of next-generation biologics and therapeutics. Supported by parent company Pump Solutions Group (PSG), the innovation permeating from CPC Biotech is set to redefine efficiency benchmarks in the biopharmaceutical space, fostering advancements that can significantly impact global health outcomes.
As the landscape of biopharmaceutical manufacturing evolves, the introduction of the RevolveSD Series marks a notable step towards enhanced operational efficiencies, positioning CPC Biotech as a leader in providing critical solutions that support sustained innovation in the healthcare sector.